SAB Biotherapeutics Stock Forecast - Naive Prediction

SABSW Stock  USD 0.07  0  4.43%   
The Naive Prediction forecasted value of SAB Biotherapeutics on the next trading day is expected to be 0.06 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.46. SAB Stock Forecast is based on your current time horizon.
  
Payables Turnover is likely to climb to 4.16 in 2024, whereas Receivables Turnover is likely to drop 3.16 in 2024. . Common Stock Shares Outstanding is likely to climb to about 9.4 M in 2024.
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the SAB Biotherapeutics' financial statements to predict how it will affect future prices.
 
Cash  
First Reported
2010-12-31
Previous Quarter
56.6 M
Current Value
59.4 M
Quarterly Volatility
18.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
A naive forecasting model for SAB Biotherapeutics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of SAB Biotherapeutics value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

SAB Biotherapeutics Naive Prediction Price Forecast For the 23rd of November

Given 90 days horizon, the Naive Prediction forecasted value of SAB Biotherapeutics on the next trading day is expected to be 0.06 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0001, and the sum of the absolute errors of 0.46.
Please note that although there have been many attempts to predict SAB Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that SAB Biotherapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

SAB Biotherapeutics Stock Forecast Pattern

Backtest SAB BiotherapeuticsSAB Biotherapeutics Price PredictionBuy or Sell Advice 

SAB Biotherapeutics Forecasted Value

In the context of forecasting SAB Biotherapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. SAB Biotherapeutics' downside and upside margins for the forecasting period are 0.0007 and 194.57, respectively. We have considered SAB Biotherapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.07
0.0007
Downside
0.06
Expected Value
194.57
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of SAB Biotherapeutics stock data series using in forecasting. Note that when a statistical model is used to represent SAB Biotherapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria110.804
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0075
MAPEMean absolute percentage error9.223372036854776E14
SAESum of the absolute errors0.4642
This model is not at all useful as a medium-long range forecasting tool of SAB Biotherapeutics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict SAB Biotherapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for SAB Biotherapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as SAB Biotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of SAB Biotherapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.0753.41
Details
Intrinsic
Valuation
LowRealHigh
0.000.0553.39
Details

Other Forecasting Options for SAB Biotherapeutics

For every potential investor in SAB, whether a beginner or expert, SAB Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. SAB Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in SAB. Basic forecasting techniques help filter out the noise by identifying SAB Biotherapeutics' price trends.

SAB Biotherapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SAB Biotherapeutics stock to make a market-neutral strategy. Peer analysis of SAB Biotherapeutics could also be used in its relative valuation, which is a method of valuing SAB Biotherapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

SAB Biotherapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of SAB Biotherapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of SAB Biotherapeutics' current price.

SAB Biotherapeutics Market Strength Events

Market strength indicators help investors to evaluate how SAB Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading SAB Biotherapeutics shares will generate the highest return on investment. By undertsting and applying SAB Biotherapeutics stock market strength indicators, traders can identify SAB Biotherapeutics entry and exit signals to maximize returns.

SAB Biotherapeutics Risk Indicators

The analysis of SAB Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in SAB Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sab stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for SAB Stock Analysis

When running SAB Biotherapeutics' price analysis, check to measure SAB Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SAB Biotherapeutics is operating at the current time. Most of SAB Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of SAB Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SAB Biotherapeutics' price. Additionally, you may evaluate how the addition of SAB Biotherapeutics to your portfolios can decrease your overall portfolio volatility.